Andrea Dorner

Berlin, BE 10785, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Adenine Nucleotide Translocase: From Nucleotide Carrier to a Modulator of Mitochondrial Bioenergetics, Quality Control, and Cellular Communication.

Adenine Nucleotide Translocase: From Nucleotide Carrier to a Modulator of Mitochondrial Bioenergetics, Quality Control, and Cellular Communication.

Journal: Cells
Published: February 26, 2026

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.

Pleiotropic Effects of the Protease-Activated Receptor 1 (PAR1) Inhibitor, Vorapaxar, on Atherosclerosis and Vascular Inflammation.

Journal: Cells
Published: November 22, 2021

Adenine Nucleotide Translocase 1 Expression Modulates the Immune Response in Ischemic Hearts.

Adenine Nucleotide Translocase 1 Expression Modulates the Immune Response in Ischemic Hearts.

Journal: Cells
Published: July 03, 2021

Mitochondria Isolated from Hearts Subjected to Ischemia/Reperfusion Benefit from Adenine Nucleotide Translocase 1 Overexpression.

Mitochondria Isolated from Hearts Subjected to Ischemia/Reperfusion Benefit from Adenine Nucleotide Translocase 1 Overexpression.

Journal: Membranes
Published: June 16, 2021

Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes.

Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes.

Journal: Cardiovascular drugs and therapy
Published: July 15, 2020

Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes.

Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes.

Journal: Cardiovascular diabetology
Published: November 06, 2019

Adenine Nucleotide Translocase 1 Expression is Coupled to the HSP27-Mediated TLR4 Signaling in Cardiomyocytes.

Adenine Nucleotide Translocase 1 Expression is Coupled to the HSP27-Mediated TLR4 Signaling in Cardiomyocytes.

Journal: Cells
Published: October 21, 2019

Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.

Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction.

Journal: European heart journal
Published: August 16, 2018

MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes.

MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes.

Journal: Cardiovascular diabetology
Published: October 30, 2017

Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?

Dabigatran-related platelet thrombin response during triple anti-thrombotic therapy: A matter of time?

Journal: Thrombosis research
Published: October 16, 2016

Transgenic overexpression of adenine nucleotide translocase 1 protects ischemic hearts against oxidative stress.

Transgenic overexpression of adenine nucleotide translocase 1 protects ischemic hearts against oxidative stress.

Journal: Journal of molecular medicine (Berlin, Germany)
Published: October 09, 2015

Adenine nucleotide translocase 1 overexpression protects cardiomyocytes against hypoxia via increased ERK1/2 and AKT activation.

Adenine nucleotide translocase 1 overexpression protects cardiomyocytes against hypoxia via increased ERK1/2 and AKT activation.

Journal: Cellular signalling
Published: July 08, 2015
Showing 1-12 of 18

Last Updated: 09/26/2026